BioCentury
ARTICLE | Financial News

Big biotech venture rounds

October 3, 2001 7:00 AM UTC

Three biotech venture financings of at least $20 million closed on Wednesday. Altus ( Cambridge, Mass.) raised $35 million in a private financing with Nomura International; U.S. Venture Partners; BankInvest; Clariden Bank; and other investors. The company is developing its crystalomics technology platform for large-scale crystallization of protein-based therapeutics.

Affibody (Stockholm, Sweden), a developer of protein ligands that mimic antibodies, raised $28 million in a private round led by Schroder Ventures Life Sciences. Other investors included HealthCap; Investor Growth Capital; and the International Biotechnology Trust. ...